Geode Capital Management’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$726K Buy
72,270
+6,505
+10% +$57.5K ﹤0.01% 3467
2026
Q1
$416K Sell
65,765
-6,492
-9% -$41.5K ﹤0.01% 3651
2025
Q4
$444K Buy
72,257
+78
+0.1% +$459 ﹤0.01% 3626
2025
Q3
$467K Buy
72,179
+327
+0.5% +$2.07K ﹤0.01% 3651
2025
Q2
$500K Buy
71,852
+2,907
+4% +$16.9K ﹤0.01% 3553
2025
Q1
$330K Buy
68,945
+4,407
+7% +$22.6K ﹤0.01% 3687
2024
Q4
$332K Buy
64,538
+7,878
+14% +$31.4K ﹤0.01% 3730
2024
Q3
$206K Buy
56,660
+962
+2% +$3.74K ﹤0.01% 3895
2024
Q2
$270K Buy
55,698
+2,485
+5% +$12K ﹤0.01% 3806
2024
Q1
$282K Hold
53,213
﹤0.01% 3819
2023
Q4
$269K Hold
53,213
﹤0.01% 3839
2023
Q3
$275K Buy
53,213
+7,486
+16% +$38K ﹤0.01% 3856
2023
Q2
$233K Buy
45,727
+7,645
+20% +$39.1K ﹤0.01% 3978
2023
Q1
$196K Hold
38,082
﹤0.01% 4060
2022
Q4
$233K Sell
38,082
-53
-0.1% -$383 ﹤0.01% 4013
2022
Q3
$285K Buy
38,135
+14,562
+62% +$119K ﹤0.01% 4017
2022
Q2
$204K Buy
23,573
+901
+4% +$7.81K ﹤0.01% 4251
2022
Q1
$218K Buy
22,672
+230
+1% +$1.99K ﹤0.01% 4336
2021
Q4
$179K Hold
22,442
﹤0.01% 4527
2021
Q3
$207K Buy
22,442
+2,008
+10% +$19K ﹤0.01% 4433
2021
Q2
$194K Hold
20,434
﹤0.01% 4353
2021
Q1
$196K Hold
20,434
﹤0.01% 4117
2020
Q4
$121K Hold
20,434
﹤0.01% 4016
2020
Q3
$110K Hold
20,434
﹤0.01% 3880
2020
Q2
$96K Hold
20,434
﹤0.01% 3868
2020
Q1
$77K Buy
+20,434
New +$101K ﹤0.01% 3837

Other funds holding ICCC

Geode Capital Management's ICCC Position: Q2 2026 in Review

Geode Capital Management increased its ImmuCell (ICCC) stake by 9.9% in Q2 2026, buying an estimated $57.5K and bringing the position to 72,270 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #3467.

Geode Capital Management first reported a position in ICCC in Q1 2020 and has held it in 26 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Geode Capital Management held 72,270 shares of ImmuCell worth $726K as of Q2 2026.
  • Geode Capital Management bought 6,505 ImmuCell shares in Q2 2026, an estimated $57.5K.
  • ImmuCell made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3467 holding.
  • Geode Capital Management first reported a position in ImmuCell in Q1 2020 and has held it in 26 quarters since.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.